On average, the COL1A2 and TNFRSF10D promoters appeared >10–fold more methylated in melanoma cell lines compared to melanocytes, and 6-fold higher in the fresh tumors (Figure S4). This evidence concerns the gene TNFRSF10D and melanoma.